Cost thresholds for anticipated long‐acting HIV pre‐exposure prophylaxis products in Eastern and Southern Africa: a mathematical modelling study
LA-PrEP is likely to require reduced pricing and/or risk-prioritized rollout to be cost-effective in ESA.
Authors
- Monisha Sharma (ORCID: https://orcid.org/0000-0002-7599-1561)
- Edinah Mudimu (ORCID: https://orcid.org/0000-0002-5479-9255)
- Linxuan Wu (ORCID: https://orcid.org/0009-0006-7240-5412)
- David Kaftan (ORCID: https://orcid.org/0000-0002-0771-1353)
- Danielle Resar (ORCID: https://orcid.org/0009-0006-3865-9523)
- Anna Bershteyn (ORCID: https://orcid.org/0000-0002-6604-7093)
- Masabho Milali
- Ingrida Platais
- Cory Arrouzet (ORCID: https://orcid.org/0000-0002-7470-3927)
- Hae‐Young Kim (ORCID: https://orcid.org/0000-0002-5124-1555)
- Sarah Yardly Jenkins (ORCID: https://orcid.org/0000-0001-5667-095X)
Institutions
- University of South Africa (ZA)
- University of Washington (US)
- Clinton Health Access Initiative (US)
- New York University (US)
Publication Details
- Journal
- Journal of the International AIDS Society
- Published
- 2025-02-01
- DOI
- https://doi.org/10.1002/jia2.26427
- Citations
- 8
- Primary Topic
- HIV/AIDS Research and Interventions
- Type
- article
- Field-Weighted Citation Impact
- 11.17